Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.

Objective: To evaluate weight gain associated with olanzapine, risperidone, and haloperidol treatment and its clinical risk factors in adolescent patients.

Method: The study was conducted at three adolescent psychiatric departments in two mental health centers in the Tel Aviv area. All patients were Jewish Israelis.